Articles
View all articles-
New drug policy to hurt pharma profitability but consumers set to gain
Stepping up its battle for cheaper medicines, the Indian government yesterday issued the Drug Price Control Order 2013, which will bring down the prices by up to 80 percent. #HowThisWorks #India #Cipla #Ranbaxy #Medicines #Drug pricing policy
-
Why the new drug price controls won't impact most consumers
What the new pricing policy does is that it replaces the earlier regime, in which prices of drugs were calculated based on the cost of manufacture, with a regime that decides the prices based on existing market prices of top selling brands. The new regime takes the average of the three brands that have one percent of the market share. #UPA #Supreme Court #CriticalPoint #Cipla #WHO #World Health Organisation #Medical #Drug Price Control Order #NLEM
-
Time India empowers its women, says Bill Clinton
Former United States president Bill Clinton on Thursday said India, which already has a track record of protecting individual rights should also look to empower women. #NewsTracker #TheySaidIt #Cipla #Ranbaxy #Bill Clinton
Wire
-
Moneycontrol.com
Cipla Medpro shareholders back buyout by India's Cipla
New to Moneycontrol - Sign up now Username should be atleast 4 characters Keep me signed in Don’t have an account? Shares in Cipla Medpro rose 1.9 percent to 9.65 rand by 0948 GMT, below the 10 rand per share offer. Like this story, share it with million #India #Africa #Cape Town
-
MSN India
Cipla Medpro shareholders approve buyout by Cipla
New Delhi, May 15 (PTI) Drug major Cipla today said shareholders of South Africa-based Cipla Medpro has approved its around USD 512 million takeover offer. Cipla in a filing to the BSE said: "The result of the general meeting of Medpro shareholders has b #New Delhi #Bombay Stock Exchange #Punjab National Bank
-
The Hindu
Cipla Medpro shareholders clear Cipla offer
The shareholders of Cipla Medpro South Africa, the Cape Town-headquartered company, have approved the takeover offer from Indian pharmaceutical major Cipla. The consideration for the acquisition is around $488 million based on Wednesday’s exchange rate o #Cape Town




